Identifying the molecular basis of Jinhong tablets against chronic superficial gastritis via chemical profile identification and symptom-guided network pharmacology analysis
Danfeng Shi,Lingxian Liu,Haibo Li,Dabo Pan,Xiaojun Yao,Wei Xiao,Xinsheng Yao,Yang Yu
DOI: https://doi.org/10.1016/j.jpha.2021.01.005
IF: 14.026
2022-02-01
Journal of Pharmaceutical Analysis
Abstract:A total of 96 chemical constituents were systematically identified or tentatively characterized by UPLC-ESI-Q/TOF-MS using the chemical profile of Jinhong tablets.We carried out a symptom-guided network pharmacology analysis of Jinhong tablets for the treatment of chronic superficial gastritis.A target screening approach was conducted based on the interaction probabilities between compounds and targets.MMP2, DRD2, and AKR1B1 are key targets of Jinhong tablets in the treatment of chronic superficial gastritis.Chronic superficial gastritis (CSG) is a common disease of the digestive system that possesses a serious pathogenesis. Jinhong tablet (JHT), a traditional Chinese medicine (TCM) prescription, exerts therapeutic effects against CSG. However, the molecular basis of its therapeutic effect has not been clarified. Herein, we employed UPLC-Q/TOF-MS-based chemical profile identification to determine the chemical components in JHT. Further, we applied network pharmacology to illustrate its molecular mechanisms. A total of 96 chemical constituents were identified in JHT, 31 of which were confirmed using reference standards. Based on the bioinformatics analysis performed using the symptom-guided pharmacological networks of "chi," "blood," "pain," and "inflammation," and a target screening based on the interaction probabilities between compounds and targets, MMP2, DRD2, and AKR1B1 were identified as key targets in the therapeutic effect exhibited by JHT against CSG. Moreover, according to the inhibitory activities presented in the literature and binding mode analysis, the structural types of alkaloids, flavonoids, organic acids, including chlorogenic acid (<strong>10</strong>), caffeic acid (<strong>13</strong>), (-)-corydalmine (<strong>33</strong>), (-)-isocorypalmine (<strong>36</strong>), isochlorogenic acid C (<strong>38</strong>), isochlorogenic acid A (<strong>41</strong>), quercetin-3-<em>O</em>-α-L-rhamnoside (<strong>42</strong>), isochlorogenic acid B (<strong>47</strong>), quercetin (<strong>63</strong>), and kaempferol (<strong>70</strong>) tended to show remarkable activities against CSG. Owing to the above findings, we systematically identified the chemical components of JHT and revealed its molecular mechanisms based on the symptoms associated with CSG.<span class="display"><span><ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2095177921000149-fx1_lrg.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download high-res image (305KB)</span></span></a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2095177921000149-fx1.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download full-size image</span></span></a></li></ol></span></span>
pharmacology & pharmacy